Azithromycin CAS Naj Npawb: 83905-01-5 Molecular Formula: C38H72N2O12

Lus piav qhia luv luv:

CAS Nr .: 83905-01-5

Lub npe tshuaj: Azithromycin

Cov roj formula: C38H72N2O12

Synonyms: (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L- ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-( dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-ib

Xa email rau peb

Product Detail

Khoom cim npe

Khoom Specification

Melting Point	115°C
Qhov ntom	1.18 g / cm³
cia temp	Inert cua, Chav Kub Kub 2-8 ° C
solubility	DMF: 16 mg/ml DMSO: 5 mg/mlm Ethanol: 16 mg/ml Ethanol: PBS (pH 7.2) (1: 1): 0.50 mg/ml
kev ua haujlwm kho qhov muag	N/A
Qhov tshwm sim	Dawb hmoov
Purity	≥98%

Kev piav qhia

Manus Aktteva Biopharma LLP, lub tuam txhab muab khoom thoob ntiaj teb thiab cov chaw muag khoom ntawm Azithromycin (CAS No.: 83905-01-5) muab rau koj cov kev xav tau ntawm RND / Kev Loj Hlob ntau lossis kev lag luam, raws li cov xwm txheej ntawm cov khoom.

DISCLAIMER: Txawm hais tias tag nrho cov kev mob siab rau yuav ua tau thiab peb yuav koom tes rau txhua yam teeb meem yog tias muaj teeb meem tshwm sim thaum lub sij hawm nrhiav, peb tsis tuaj yeem lav lub luag haujlwm rau kev ua tsis raws cai lossis teeb meem hauv kev lag luam uas yuav tshwm sim, uas yog dhau ntawm peb tswj. Cov khoom poob nyob rau hauv kev tswj cov tshuaj qeb / daim ntawv teev cov tshuaj yuav tsum raug xa tawm ncaj qha los ntawm cov chaw tsim khoom lag luam tsuas yog tawm tsam tau txais daim ntawv tso cai tseem ceeb uas tau muab los ntawm cov koom haum cuam tshuam ntawm lub teb chaws tuaj txawv teb chaws. txoj cai hauv cheeb tsam lossis thoob ntiaj teb.Peb cov ntaub ntawv pej xeem hais txog peb qhov kev ntseeg tau.Peb tsis txhawb lossis xav ua ib feem ntawm cov koom haum ntiag tug lossis pej xeem los ua pov thawj peb txoj kev ua raws cai.

PATENTS Cov khoom muaj kev tiv thaiv los ntawm patents siv tau tsis muaj muag hauv cov teb chaws uas kev muag khoom ntawm cov khoom no suav nrog kev ua txhaum cai patent thiab nws lub luag haujlwm yog nyob ntawm tus neeg yuav khoom muaj kev pheej hmoo.Cov khoom tam sim no them los ntawm US Patents uas siv tau yog muab rau R&D siv raws li 35 USC 271 +A13(1) •Manus Aktteva Biopharma LLP tsis muaj lub luag haujlwm / kev lav phib xaub yog tias tau muab faib nrog cov khoom uas cuam tshuam txog kev txawj ntse ntawm txhua yam uas suav nrog patent txoj cai ntawm ib tug neeg twg.Manus Aktteva Biopharma LLP ua rau tsis muaj kev sawv cev lossis kev lees paub ntawm txhua yam, qhia lossis qhia, hais txog qhov qub lossis kev ntseeg siab ntawm cov cuab yeej cuab tam uas suav nrog patents hauv nws cov khoom lossis kev pabcuam rau txhua lub hom phiaj.Manus Aktteva Biopharma LLP ceeb toom cov neeg muag khoom kom tsis txhob muag cov khoom lag luam uas cuam tshuam txog kev txawj ntse ntawm txhua yam uas suav nrog cov cai patent ntawm ib tus neeg twg.Manus Aktteva Biopharma LLP ceeb toom cov neeg yuav khoom tsis txhob siv / yuav khoom kom ua tiav cov khoom lag luam uas yuav paub txog ua rau muaj kev cuam tshuam ntawm cov cuab yeej cuab tam hauv txhua yam uas suav nrog cov cai patent ntawm ib tus neeg twg.

kev siv thiab ntau npaum li cas

Azithromycin yog ib tug semi-synthetic, nplhaib-expanded erythromycin tsim los ntawm ib tug Beckmann rearrangement ntawm erythromycin oxime thiab txo mus rau lub imine ether, ua raws li reductive methylation.Azithromycin yog thawj zaug ntawm azalides thiab tau tsim los txhim kho kev ruaj ntseg thiab lom ib nrab ntawm lub neej ntawm erythromycin A, nrog rau kev txhim kho kev ua haujlwm ntawm cov kab mob Gram tsis zoo.Txij li thaum nws nrhiav tau nyob rau hauv 1980 los ntawm Djokic thiab cov neeg ua hauj lwm, azithromycin tau txaus siab rau kev kho mob zoo heev.